R oS5 510(k) Summary 1.0 Submitted By:

First Page		Document Content
Date: 2011-02-17 14:36:01 Immunoassay Phospholipase A2 Lipoprotein-associated phospholipase A2 ELISA Medical device Cardiovascular disease Lipoprotein Premarket approval Atherosclerosis Medicine Immunologic tests Peripheral membrane proteins		R oS5 510(k) Summary 1.0 Submitted By: Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 169,53 KB Share Document on Facebook

	Am J Cardiovasc Dis 2015;5(1):53-62 www.AJCD.us /ISSN:2160-200X/AJCD0007056 Original Article Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice DocID: 1tdZW - View Document
	DGFF (Lipid-Liga) e. V. veröffentlicht Empfehlungen für die ärztliche Praxis zu „Lipoprotein (a): ein unabhängiger kardiovaskulärer Risikofaktor“ PRESSE-INFO DocID: 1sxmj - View Document
	Projects Dieplinger Lab Work in our research group has concentrated in the past 25 years on the metabolism and genetics of various components of the human lipid/lipoprotein system and their impact on modern widespread di DocID: 1rIvQ - View Document
	957 ORIGINAL ARTICLE Asymmetrical dimethyl arginine in type 2 diabetic patients with coronary artery disease Kalsoom Tariq, Mudassir Ahmad Khan DocID: 1rmCz - View Document
	ORIGINAL RESEARCH Effects of Vegetarian Diets on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Fenglei Wang, MS; Jusheng Zheng, PhD; Bo Yang, MPH; Jiajing Jiang, MS; Yuanqing Fu, Ph DocID: 1rlXt - View Document